Peter Jönsson
About
Peter Jönsson is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine.
According to data from OpenAlex, Peter Jönsson has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Surgery and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Peter Jönsson's work include Growth Hormone and Insulin-like Growth Factors (32 papers), Pituitary Gland Disorders and Treatments (25 papers) and Lipid metabolism and disorders (7 papers). Peter Jönsson is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (32 papers), Pituitary Gland Disorders and Treatments (25 papers) and Lipid metabolism and disorders (7 papers). Peter Jönsson collaborates with scholars based in Sweden, United States and United Kingdom. Peter Jönsson's co-authors include Maria Kołtowska‐Häggström, John P. Monson, Roger Abs, Pat Kendall‐Taylor, Mitchell E. Geffner, David A. Price, Johan Verhelst, Patrick Wilton, Beverly M. K. Biller and Ulla Feldt‐Rasmussen and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Archives of Physical Medicine and Rehabilitation and Clinical Endocrinology.
In The Last Decade
Peter Jönsson
33 papers receiving 1.0k citations
Peers
Peter Jönsson
PM Stewart United Kingdom
Silvia Rovere Italy
G. Götherström Sweden
Elizabeth Hernberg‐Ståhl United Kingdom
B-Å Bengtsson Sweden
Paola Razzore Italy
Margreet A. E. M. Wagenmakers Netherlands
H. Rosemarie Davidson United Kingdom
Chiara Giulia Croce Italy
B Westberg Sweden
Citations per year, relative to Peter Jönsson Peter Jönsson (= 1×)
peers
PM Stewart
Countries citing papers authored by Peter Jönsson
Since
Specialization
Citations
This map shows the geographic impact of Peter Jönsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Jönsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Jönsson more than expected).
Fields of papers citing papers by Peter Jönsson
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Peter Jönsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Jönsson. The network helps show where Peter Jönsson may publish in the future.
Co-authorship network of co-authors of Peter Jönsson
This figure shows the co-authorship network connecting the top 25 collaborators of Peter Jönsson. A scholar is included among the top collaborators of Peter Jönsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Jönsson. Peter Jönsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Buchfelder, Michael, Aart‐Jan van der Lely, Beverly M. K. Biller, et al.. (2018). Long-term treatment with pegvisomant: observations from 2090 acromegaly patients in ACROSTUDY. European Journal of Endocrinology. 179(6). 419–427.
2.
Thankamony, Ajay, Donatella Capalbo, Peter Jönsson, Helen Simpson, & David B. Dunger. (2016). Predictors of Insulin-Like Growth Factor-I Responses to Growth Hormone Replacement in Young Adults with Growth Hormone Deficiency. Hormone Research in Paediatrics. 85(6). 379–388.
3.
Tritos, Nicholas A., Philippe Chanson, Camilo Jiménez, et al.. (2016). Effectiveness of first-line pegvisomant monotherapy in acromegaly: an ACROSTUDY analysis. European Journal of Endocrinology. 176(2). 213–220.
4.
Freda, Pamela U., Murray B. Gordon, Nicky Kelepouris, et al.. (2014). Long-Term Treatment with Pegvisomant as Monotherapy in Patients with Acromegaly: Experience from Acrostudy. Endocrine Practice. 21(3). 264–274.
5.
Lely, A. J. van der, Roy Gomez, Ann‐Charlotte Åkerblad, et al.. (2014). Pregnancy in acromegaly patients treated with pegvisomant. Endocrine. 49(3). 769–773.
6.
Yuen, Kevin C.J., Maria Kołtowska‐Häggström, David M. Cook, et al.. (2013). Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic–pituitary dysfunction. European Journal of Endocrinology. 169(4). 511–519.
7.
Ragnarsson, Óskar, Charlotte Höybye, Peter Jönsson, et al.. (2012). Comorbidity and cardiovascular risk factors in adult GH deficiency following treatment for Cushing's disease or non-functioning pituitary adenomas during childhood. European Journal of Endocrinology. 166(4). 593–600.
8.
Tritos, Nicholas A., Amir H. Hamrahian, Donna King, et al.. (2012). A longer interval without GH replacement and female gender are associated with lower bone mineral density in adults with childhood-onset GH deficiency: a KIMS database analysis. European Journal of Endocrinology. 167(3). 343–351.
9.
Tritos, Nicholas A., Amir H. Hamrahian, Donna King, et al.. (2012). Predictors of the effects of 4 years of growth hormone replacement on bone mineral density in patients with adult‐onset growth hormone deficiency – a KIMS database analysis. Clinical Endocrinology. 79(2). 178–184.
10.
Höybye, Charlotte, Óskar Ragnarsson, Peter Jönsson, et al.. (2010). Clinical features of GH deficiency and effects of 3 years of GH replacement in adults with controlled Cushing's disease. European Journal of Endocrinology. 162(4). 677–684.
11.
Abrams, Pascale, Hugo Boquete, Hugo Fideleff, et al.. (2008). GH replacement in hypopituitarism improves lipid profile and quality of life independently of changes in obesity variables. European Journal of Endocrinology. 159(6). 825–832.
12.
Monson, John P., Peter Jönsson, Maria Kołtowska‐Häggström, & IONE A. KOURIDES. (2007). Growth hormone (GH) replacement decreases serum total and LDL‐cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy. Clinical Endocrinology. 67(4). 623–628.
13.
Höybye, Charlotte, Peter Jönsson, John P. Monson, et al.. (2007). Impact of the primary aetiology upon the clinical outcome of adults with childhood-onset GH deficiency. European Journal of Endocrinology. 157(5). 589–596.
14.
Gutiérrez, Lia, Maria Kołtowska‐Häggström, Peter Jönsson, et al.. (2007). Registries as a tool in evidence‐based medicine: example of KIMS (Pfizer International Metabolic Database). Pharmacoepidemiology and Drug Safety. 17(1). 90–102.
15.
Verhelst, Johan, Pat Kendall‐Taylor, Eva Marie Erfurth, et al.. (2005). Baseline Characteristics and Response to 2 Years of Growth Hormone (GH) Replacement of Hypopituitary Patients with GH Deficiency due to Adult-Onset Craniopharyngioma in Comparison with Patients with Nonfunctioning Pituitary Adenoma: Data from KIMS (Pfizer International Metabolic Database). The Journal of Clinical Endocrinology & Metabolism. 90(8). 4636–4643.
16.
Kendall‐Taylor, Pat, Peter Jönsson, Roger Abs, et al.. (2005). The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma. European Journal of Endocrinology. 152(4). 557–567.
17.
Casanueva, Felipe F., Alfonso Leal, Maria Kołtowska‐Häggström, Peter Jönsson, & Miklós Góth. (2005). Traumatic brain injury as a relevant cause of growth hormone deficiency in adults: A KIMS-based study. Archives of Physical Medicine and Rehabilitation. 86(3). 463–468.
18.
Monson, John P. & Peter Jönsson. (2003). Aspects of Growth Hormone (GH) Replacement in Elderly Patients with GH Deficiency: Data from KIMS. Hormone Research in Paediatrics. 60(Suppl. 1). 112–120.
19.
Mukherjee, Annice, John P. Monson, Peter Jönsson, Peter Trainer, & Stephen M. Shalet. (2003). Seeking the Optimal Target Range for Insulin-Like Growth Factor I during the Treatment of Adult Growth Hormone Disorders. The Journal of Clinical Endocrinology & Metabolism. 88(12). 5865–5870.
20.
Petersson, Jesper, Peter M. Zygmunt, Peter Jönsson, & Edward D. Högestätt. (1998). Characterization of Endothelium- Dependent Relaxation in Guinea Pig Basilar Artery – Effect of Hypoxia and Role of Cytochrome P<sub>450</sub> Mono-Oxygenase. Journal of Vascular Research. 35(4). 285–294.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by PM Stewart Breakdown of academic impact, for papers by Silvia Rovere Breakdown of academic impact, for papers by G. Götherström Breakdown of academic impact, for papers by Elizabeth Hernberg‐Ståhl Breakdown of academic impact, for papers by B-Å Bengtsson Breakdown of academic impact, for papers by Paola Razzore Breakdown of academic impact, for papers by Margreet A. E. M. Wagenmakers Breakdown of academic impact, for papers by H. Rosemarie Davidson Breakdown of academic impact, for papers by Chiara Giulia Croce Breakdown of academic impact, for papers by B Westberg